Clinical Trials Sponsored by Luxia Scientific

Total 2045 results

Boston Scientific Corporation

Completed

An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins

Varicose Veins

United States
Boston Scientific Corporation

Completed

Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study - (CAFE)

Atrial Fibrillation
Boston Scientific Corporation

Terminated

Effects of Programming Parameters on Back Pain Relief in Subthreshold Spinal Cord Stimulation

Low Back Pain

Australia
Boston Scientific Corporation

Completed

Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence (Pilot)

Varicose Veins

United States
Boston Scientific Corporation

Completed

Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities (017)

Great Saphenous Vein Incompetence | Visible Varicosities

United States
Boston Scientific Corporation

Completed

Longitudinal Surveillance Study of the 4-SITE Lead/Header System (LSS of 4-SITE)

Primary Prevention of Sudden Cardiac Arrest | Secondary Prevention of Sudden Cardiac Arrest

United States, Canada, Australia
Boston Scientific Corporation

Completed

Bronchial Thermoplasty in Severe Persistent Asthma (PAS2)

Severe Asthma

United States, Canada
Boston Scientific Corporation

Terminated

A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma (SOLACE)

Hepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma

United States
Boston Scientific Corporation

Completed

Research in Severe Asthma (RISA) Trial

Asthma
Boston Scientific Corporation

Completed

ACC - Atrial Contribution to CRT

Dilated Cardiomyopathy

Denmark
Boston Scientific Corporation

Completed

Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)

Hypertension

United States
Boston Scientific Corporation

Completed

Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude (WHISPER)

Chronic Pain

United States
Boston Scientific Corporation

Withdrawn

Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma (3to2)

Asthma
Boston Scientific Corporation

Terminated

Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)

Chronic Neuropathic Pain in the Low Back and Legs

United Kingdom
Boston Scientific Corporation

Completed

Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing

Heart Block | Bradycardia | Sick Sinus Syndrome

France, Guadeloupe
Boston Scientific Corporation

Completed

ENABLE MRI (Magnetic Resonance Imaging) (ENABLE-MRI)

Magnetic Resonance Imaging

Spain, Hong Kong, Germany, Israel, United Kingdom, Italy, United States, Malaysia, Belgium
Boston Scientific Corporation

Completed

Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy (nCYT)

Ovarian Diseases | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Carcinoma | Fallopian Tube Adenocarcinoma | High Grade Serous Carcinoma | Ovary Cancer | Adnexal Mass

United States
Boston Scientific Corporation

Withdrawn

Boston Scientific's Single Shot LUMINIZE RF Balloon Catheter in the Treatment of Symptomatic, Drug Refractory Paroxysmal Atrial Fibrillation (VISUALISE AF)

Paroxysmal Atrial Fibrillation
Boston Scientific Corporation

Completed

Evaluation of PCLs Using Three EUS-FNA Needles

Pancreatic Cystic Lesions

United States, China, India
Boston Scientific Corporation

Completed

Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads (NAVIGATE X4)

Cardiac Resynchronization Therapy

United States
Boston Scientific Corporation

Terminated

Efficacy of the Spinal Cord Stimulation System as Salvage Therapy

Pain | Chronic Pain | Intractable Pain

United States
Boston Scientific Corporation

Completed

Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System

Mitral Valve Insufficiency

Brazil, Paraguay
Boston Scientific Corporation

Completed

Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain

Chronic Pain

Spain, Belgium, Australia
Boston Scientific Corporation

Completed

Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector (RESCUE)

Chronic Pain

United States
Boston Scientific Corporation

Withdrawn

Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)

Atrial Tachycardia (Including Atrial Flutter) Post Atrial Fibrillation Ablation or Cardiac Surgery

China
Boston Scientific Corporation

Completed

Bronchial Thermoplasty 10+ Year Study

Asthma

United States, Netherlands, United Kingdom, Brazil, Canada
Boston Scientific Corporation

Completed

Safety and Performance Study of the INGEVITY Lead

Bradycardia | Sinus Node Dysfunction

United States, Belgium, Germany, Canada, Spain, Sweden, Italy, Malaysia, Denmark, Australia, Austria, United Kingdom, Hong Kong, France, Portugal, Thailand
Quadras Scientific Solutions

Completed

A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions

Lung Cancer
Boston Scientific Corporation

Terminated

Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population

Indication for Modification of Patient Physical Status

China
Boston Scientific Corporation

Completed

Bronchial Thermoplasty Global Registry (BTGR)

Asthma

Spain, Italy, Germany, Netherlands, Australia, Czechia, South Africa, United Kingdom
Boston Scientific Corporation

Completed

Performance and Safety of the Lotus™ Valve With a FLEXible Delivery System

Aortic Stenosis

Australia
Boston Scientific Corporation

Withdrawn

REPRISE EDGE 29 mm EU Study

Aortic Valve Stenosis
Boston Scientific Corporation

Completed

Registry on WATCHMAN Outcomes in Real-Life Utilization (EWOLUTION)

Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke

Ireland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions (PLATINUM)

Coronary Artery Disease

United States, Denmark, Australia, Germany, Belgium, Finland, Netherlands, New Zealand, France, United Kingdom, Malaysia, Japan, Singapore, Poland, Latvia, Austria, Portugal
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) (PLATINUM LL)

Coronary Artery Disease

United States, Australia, Latvia, Belgium, France, New Zealand, Japan
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels (PLATINUM SV)

Coronary Artery Disease

United States, Australia, France, Belgium, New Zealand, Japan
Boston Scientific Corporation

Completed

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy (MIRACLEIII)

Colorectal Carcinoma

Italy
Boston Scientific Corporation

Completed

Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)

Peripheral Arterial Disease

Japan
Boston Scientific Corporation

Completed

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation (ZERO-AF)

Paroxysmal Atrial Fibrillation (PAF)

United States, Spain, Germany, Australia, United Kingdom, Sweden, Czechia, France, Portugal
Boston Scientific Corporation

Completed

Self-Centering Guide Catheter Feasibility Study

Aortic Stenosis

United States
Boston Scientific Corporation

Completed

SpyGlass Direct Visualization System Clinical Registry in China (SpyChina)

Biliary Tract Diseases

China
Boston Scientific Corporation

Completed

PROMUS Element Plus US Post-Approval Study

Coronary Artery Disease

United States
Boston Scientific Corporation

Completed

Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy (PREVAIL)

Stroke | Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter (BLOCk-CTI)

Atrial Flutter

United States
Boston Scientific Corporation

Completed

The Captivator EMR Registry

Barrett's Esophagus

United States, Canada, Belgium, United Kingdom, Netherlands, Germany
Boston Scientific Corporation

Completed

Prospective Registry on User Experience With The Mapping System For Ablation Procedures (TRUE-HD)

Cardiac Arrhythmias

United States, Netherlands, Hong Kong, France, Spain, Germany, Australia, United Kingdom
Boston Scientific Corporation

Completed

ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial (COCOA-BP)

Blood Pressure | Health Behavior
Boston Scientific Corporation

Completed

REASSURE AV Registry (REASSURE)

Bradycardia | Sudden Cardiac Death

United States
Boston Scientific Corporation

Terminated

Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction (RESET)

Heart Failure

United States
Boston Scientific Corporation

Completed

IntellaTip MiFi XP Ablation Catheter Trial (MiFi-CTI)

Atrial Flutter

Australia

Clinical Trials Sponsored by Luxia Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations